PBYI Earnings & Financial Statements
Puma Biotechnology, Inc.
$9.90
+$0.09(+0.92%)
63
Overall
80
Value
54
Tech
57
Quality
Market Cap
$506.39M
Volume
118.47K
52W Range
$4.58 - $10.10
Target Price
$11.00
PBYI earnings and financial statements: Puma Biotechnology, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
PBYI Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $228.37M | $230.47M | $235.64M | $228.03M | $253.16M |
| Cost of revenue | $58.16M | $64.40M | $62.68M | $55.09M | $63.70M |
| Operating income | $37.30M | $30.97M | $32.64M | $23.72M | $1.29M |
| EBITDA | $53.34M | $48.08M | $47.52M | $21.89M | -$4.69M |
| Net income | $31.11M | $30.28M | $21.59M | $2.0K | -$29.13M |
| EPS (diluted) | $0.61 | $0.62 | $0.45 | - | $-0.72 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $216.30M | $213.33M | $230.53M | $222.06M | $226.59M |
| Total liabilities | $85.96M | $121.21M | $177.09M | $200.45M | $229.03M |
| Shareholders’ equity | $130.34M | $92.13M | $53.44M | $21.61M | -$2.45M |
| Cash and equivalents | $29.64M | $69.22M | $84.58M | $76.20M | $63.13M |
| Long-term debt | $4.71M | $23.21M | $72.69M | $110.14M | $113.07M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $41.80M | $38.92M | $27.01M | -$15.83M | $20.65M |
| Capital expenditure | -$71.0K | -$56.0K | -$12.64M | -$7.00M | - |
| Free cash flow | $41.73M | $38.86M | $14.37M | -$22.83M | $20.65M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PBYI | $9.90 | +0.9% | 118.47K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Puma Biotechnology, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW